Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b000fe0f48644f0b3b98f93aaef93a45 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_18e76a2a7c8e804d5cb382a5f0812a11 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-18532 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-208 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-45 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-177 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-768 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-535 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-155 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-768 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-76 |
filingDate |
2008-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f1887c3bd09a610a5f7ae4d07bf450f0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d17015b60cfa38cb331f7c7a0c09609 |
publicationDate |
2010-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2010303839-A1 |
titleOfInvention |
Methods and compositions for treatment of cancer using oncolytic rsv activity |
abstract |
The present invention relates generally to methods and compositions employing the oncolytic activity of respiratory syncytial virus (RSV) to treat cancer and other neoplastic disorders. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8597637-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9289456-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7034521-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9233132-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017122946-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9044499-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9060974-B1 |
priorityDate |
2007-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |